News
Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...
TNX-1700 is in preclinical development for gastric and colorectal cancers ...
The data, presented in a poster titled "AP402, a bispecific antibody targeting p95HER2 and CD137, shows potent antitumor activity," highlight the therapeutic potential of AP402 to address ...
Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results